# Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

> **NCT00314613** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Antipsychotic/Risperidone Consta

## Key facts

- **NCT ID:** NCT00314613
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314613, "Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00314613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*